Novartis AG (NEO:NVS)

Market Cap	306.69B
Revenue (ttm)	75.27B
Net Income (ttm)	18.62B
Shares Out	n/a
EPS (ttm)	9.34
PE Ratio	16.47
Forward PE	13.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	185
Average Volume	368
Open	21.67
Previous Close	22.38
Day's Range	21.67 - 21.67
52-Week Range	20.11 - 24.03
Beta	n/a
RSI	24.48
Earnings Date	Jul 17, 2025

About Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Re...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Cboe Canada
• Ticker Symbol: NVS

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD